Local injection of TSLP antibodies in the psoriasis-like mouse model led to skin inflammation regression, reduced epidermal hyperplasia, decreased vascular endothelial growth factor α expression, and epidermal inhibition of STAT-5 phosphorylation (74). The gene discussed is TSLP; the disease is psoriasis.